Trial intelligence / Profile preview

Fosfomycin vs Standard of Care in Children with Antibiotic-resistant UTIs

NCT05709028Phase 3Recruiting

Sponsor
University of Sydney
Start
Aug 2023
Primary completion
Aug 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fosfomycin in urinary tract infection (UTI), sponsored by University of Sydney. Started Aug 2023; status: recruiting.

02

Drugs

fosfomycin
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on NCT05709028.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05709028.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call